Annovis Bio (ANVS)
(Delayed Data from NYSE)
$4.82 USD
-0.53 (-9.91%)
Updated May 8, 2024 04:00 PM ET
After-Market: $4.95 +0.13 (2.70%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.87 | 0.00% |
Earnings Summary
For their last quarter, Annovis Bio (ANVS) reported earnings of -$1.09 per share, beating the Zacks Consensus Estimate of $-1.35 per share. This reflects a positive earnings surprise of 19.26%. Look out for ANVS's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.87 per share, reflecting a year-over-year increase of 26.89%.
Earnings History
Price & Consensus
Zacks News for ANVS
Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services